MSACL 2019
24-26 September 2019

Join Agilent at MSACL 2019 EU

Salzburg | Austria | Booth #19-20

Agilent welcomes you to Salzburg!

Agilent is proud to announce its participation as a sponsor at the 6th Annual European Congress & Exhibition for MSACL EU, on the 24-26 September 2019.

Poster presentation

Fast Multiplexed Analysis of Cannabinoids and their Metabolites in Urine Using MassHunter StreamSelect LC-MS System.

Poster Number: 11c 
Date: Wednesday 25 September, 2019
Time: 9:30 a.m.
Location: Exhibit Hall

Join our scientific workshop on Wednesday 25 September at 1:30 p.m. - 2:15 p.m. in Trakl (2nd Floor)

Fast Track your Cannabinoid Urine Analysis using MassHunter StreamSelect LC-MS System
Speaker: Moritz Wagner, Product Specialist, Agilent Technologies

Abstract: Liquid chromatography triple quadrupole mass spectrometry (LC/MS/MS) is the ideal solution for the simultaneous analysis of multiple cannabinoids and metabolites due to the high specificity and analytical sensitivity of the instrumentation.  A six-minute chromatographic method was developed on an Agilent Poroshell 120 EC-C18 column to separate 6 cannabinoids analytes using an Agilent 1290 Infinity II Liquid Chromatograph coupled with an Agilent 6470 triple quadrupole mass spectrometer. Sample throughput was nearly quadrupled (3.7x) by running four simultaneous, staggered chromatographic analyses on a single mass spectrometer using Agilent’s MassHunter StreamSelect LC-MS software. This equates to 97 seconds per analysis, compared to a 6-minute runtime the same analysis using traditional LC-MS.

Please ensure to register for the scientific workshop, as seats are limited.

Please note, you must be officially registered for the MSACL 2019 EU Conference to be able to attend any Agilent activities.

For Research Use Only. Not for use in diagnostic procedures.

Your Personal Data

* This field is required

Please select your application interest(s) from choices below.

Please select your technique(s) from choices below.

Your Purchase Plan

For full details of how we will treat your information please view our privacy policy: